The determinants of elevated total plasma cholesterol levels in cardiac transplant recipients administered low dose cyclosporine for immunosuppression-Reference-Cited by-同舟云学术

The determinants of elevated total plasma cholesterol levels in cardiac transplant recipients administered low dose cyclosporine for immunosuppression

Published:1992-08 Issue:2 Volume:104 Page:241-247
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

Laufer Günther,Grablowitz Viktor,Laczkovics Axel,Miholic Johannes,Heinz Gottfried,Wollenek Gregor,Schreiner Wolfgang,Wolfram Johanna,Wolner Ernst

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference25 articles.

1. Monoclonal versus polyclonal antibody therapy for prophylaxis against rejection after heart transplantation;Kormos;J Heart Transplant,1990

2. Cyclosporine and azathioprine immunosuppression without maintenance steroids: a prospective randomized trial;Esmore;J Heart Transplant,1989

3. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone;Uretsky;Circulation,1987

4. Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient;Gao;Circulation,1987

5. Hyperlipidemia after heart transplantation;Keogh;J Heart Transplant,1988

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppression in Renal Transplantation and Dyslipidemia, Which Factors Should Be Considered?;Nephro-Urology Monthly;2013-11-13

2. Statins and the Risk of Cancer After Heart Transplantation;Circulation;2012-07-24

3. Plasma Kinetics of a Cholesterol-Rich Microemulsion in Patients Submitted to Heart Transplantation;Transplantation;2004-10-27

4. Effect of atorvastatin on postcardiac transplant increase in low-density lipoprotein cholesterol reduces development of intimal hyperplasia and progression of endothelial dysfunction;The American Journal of Cardiology;2003-07

5. CHYLOMICRON METABOLISM IN PATIENTS SUBMITTED TO CARDIAC TRANSPLANTATION1;Transplantation;2000-02